Department of Human Genetics, University of Michigan, Ann Arbor, MI, 48109-5618, USA.
Department of Microbiology and Immunology, University of Michigan, Ann Arbor, MI, 48109-5618, USA.
Sci Rep. 2019 Jul 3;9(1):9609. doi: 10.1038/s41598-019-45939-w.
Defective biosynthesis of the phospholipid PI(3,5)P underlies neurological disorders characterized by cytoplasmic accumulation of large lysosome-derived vacuoles. To identify novel genetic causes of lysosomal vacuolization, we developed an assay for enlargement of the lysosome compartment that is amenable to cell sorting and pooled screens. We first demonstrated that the enlarged vacuoles that accumulate in fibroblasts lacking FIG4, a PI(3,5)P biosynthetic factor, have a hyperacidic pH compared to normal cells'. We then carried out a genome-wide knockout screen in human HAP1 cells for accumulation of acidic vesicles by FACS sorting. A pilot screen captured fifteen genes, including VAC14, a previously identified cause of endolysosomal vacuolization. Three genes not previously associated with lysosome dysfunction were selected to validate the screen: C10orf35, LRRC8A, and MARCH7. We analyzed two clonal knockout cell lines for each gene. All of the knockout lines contained enlarged acidic vesicles that were positive for LAMP2, confirming their endolysosomal origin. This assay will be useful in the future for functional evaluation of patient variants in these genes, and for a more extensive genome-wide screen for genes required for endolysosome function. This approach may also be adapted for drug screens to identify small molecules that rescue endolysosomal vacuolization.
磷脂酰肌醇 3,5 二磷酸(PI(3,5)P)的生物合成缺陷是导致以细胞质中大量溶酶体衍生的空泡积累为特征的神经紊乱的基础。为了确定溶酶体空泡化的新遗传原因,我们开发了一种可用于细胞分选和 pooled 筛选的溶酶体区室扩大测定法。我们首先证明,在缺乏 PI(3,5)P 生物合成因子 FIG4 的成纤维细胞中积累的扩大的空泡与正常细胞相比具有更高的酸性 pH 值。然后,我们在人 HAP1 细胞中进行了全基因组敲除筛选,以通过 FACS 分选来积累酸性囊泡。初步筛选捕获了十五个基因,包括 VAC14,这是先前鉴定的导致内溶酶体空泡化的原因。选择了三个以前与溶酶体功能障碍无关的基因来验证筛选结果:C10orf35、LRRC8A 和 MARCH7。我们分析了每个基因的两个克隆敲除细胞系。所有敲除系都含有扩大的酸性囊泡,这些囊泡对 LAMP2 呈阳性,证实了它们的内溶酶体起源。该测定法将有助于将来对这些基因的患者变异进行功能评估,以及对参与内溶酶体功能的基因进行更广泛的全基因组筛选。这种方法也可以适用于药物筛选,以鉴定能够挽救内溶酶体空泡化的小分子。